Live Breaking News & Updates on Rev Anticancer|Page 1
Stay updated with breaking news from Rev anticancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The CALLA Phase III trial for AstraZeneca’s Imfinzi (durvalumab) given concurrently with chemoradiotherapy (CRT) did not achieve statistical significance for. ....
Beyond issuing guidance documents, what actions has the FDA taken to ensure inclusion of relevant patient populations in cancer clinical trials? And. ....